AstraZeneca’s Susan Galbraith To Lead Its Entire Cancer R&D
Takes on José Baselga’s Role
After more that 10 years at the firm, Susan Galbraith has taken on an expanded role heading up oncology R&D at AstraZeneca.
After more that 10 years at the firm, Susan Galbraith has taken on an expanded role heading up oncology R&D at AstraZeneca.